← Back to home

EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION)

Clinical trials for EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION) explained in plain language.

Never miss a new study

Get alerted when new EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION) trials appear

Sign up with your email to follow new studies for EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hormone combo may help young women beat early uterine cancer without losing fertility

Disease control Recruiting now

This study tests whether a combination of two hormone drugs (GnRHa and letrozole) works better than standard hormone pills (megestrol or medroxyprogesterone) for treating early-stage endometrial cancer while preserving the ability to have children. About 104 women with stage I, l…

Matched conditions: EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION)

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jun 16, 2026 12:53 UTC

EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION)

Get alerted when new EARLY-STAGE ENDOMETRIAL CANCER (ENDOMETRIOID, GRADE I, WITHOUT MYOMETRIAL INVASION) trials appear

New hormone combo may help young women beat early uterine cancer without losing fertility